Absolutely. There's huge potential in making customized treatments that can sequence the patient's DNA, for example, for cancer, figuring out which particular mutations they have in their cancer cells and develop a custom treatment just for them. There are absolutely incredible opportunities there.
I'm a firm believer in innovation and in private sector innovation and the key to get this is to create the right incentives. In pharma, in aviation, and restaurants even, industry innovates to produce safe products where the harm outweighs the good, because those are the ones that they're allowed to sell. If we can quickly create the correct incentives for the AI industry, then these companies that are currently doing, in my opinion, very reckless things will quickly focus on innovating a race to the top with safe products. I don't blame the companies. I blame the lack of providing the right incentives to them.